1. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS;Matsumura;Cancer Res.,1986
2. Tumoritropic and lymphotropic principles of macromolecular drugs;Maeda;Crit. Rev. Ther. Drug Carrier Syst.,1989
3. Doxorubicin-polymer conjugates: Further demonstration of the concept of enhanced permeability and retention;Muggia;Clin. Cancer Res.,1999
4. SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy;Maeda;Adv. Drug Delivery Rev.,1991
5. Phase I clinical and pharmacokinetic study of PK1 (HPMA copolymer doxorubicin): First member of a new class of chemotherapeutic agents–drug–polymer conjugates;Vasey;Clin. Cancer Res.,1999